Medpace Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Medpace Holdings (MEDP).

Price Target Range — 12 Quarters

Analyst Consensus — 14 Analysts

4Buy

10Hold

Consensus RatingHold# Analysts14Avg. Consensus PT$556Upside to Avg. PT-13.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 26, 2026	BMO Capital	Sean Dodge	PT Raise	Market Perform	$600→$670
Oct 23, 2026	UBS	Kevin Caliendo	PT Raise	Neutral	$673→$700
Oct 23, 2026	Truist Securities	Jailendra Singh	PT Raise	Hold	$609→$633
Oct 23, 2026	Barclays	Luke Sergott	PT Raise	Equal-Weight	$625→$675
Oct 23, 2026	TD Cowen	Charles Rhyee	PT Raise	Hold	$492→$673
Oct 7, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$665→$700
Oct 7, 2026	Barclays	Luke Sergott	PT Raise	Equal-Weight	$600→$625
Sep 30, 2026	UBS	Kevin Caliendo	Upgrade	Sell→Neutral	$405→$673
Jul 24, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$586→$665
Jul 24, 2026	BMO Capital	Sean Dodge	PT Raise	Market Perform	$400→$600
Jul 24, 2026	Truist Securities	Jailendra Singh	PT Raise	Hold	$462→$609
Jul 24, 2026	TD Cowen	Charles Rhyee	PT Raise	Hold	$419→$492
Jul 24, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$484→$692
Jul 24, 2026	Baird	Eric Coldwell	PT Raise	Neutral	$547→$624
Jul 13, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$495→$586
Jul 8, 2026	Baird	Eric Coldwell	Downgrade	Outperform→Neutral	$477→$547
Jul 7, 2026	Jefferies	David Windley	Downgrade	Buy→Hold	$490→$515
Apr 24, 2026	Barclays	Luke Sergott	PT Cut	Equal-Weight	$500→$450
Apr 24, 2026	BMO Capital	Sean Dodge	PT Cut	Market Perform	$460→$400
Apr 24, 2026	RBC Capital	Ryan Halsted	PT Cut	Outperform	$522→$484

Analyst Ratings News

PRO
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670

BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $600 to $670.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700

UBS analyst Kevin Caliendo maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $673 to $700.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633

Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $609 to $633.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673

TD Cowen analyst Charles Rhyee maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $492 to $673.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.

Benzinga Newsdesk

Medpace Holdings Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Medpace Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670

PRO
UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700

PRO
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633

PRO
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

PRO
TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700

People Also Watch

People Also Watch

Medpace Holdings Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Medpace Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670

PROUBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700

PROTruist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633

PROBarclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

PROTD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673

PROMizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700

People Also Watch

People Also Watch

PRO
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670

PRO
UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700

PRO
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633

PRO
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

PRO
TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700